1. ACC Position Statement. Catheter ablation position for cardiac arrhythmias. Clinical applications, personnel and facilities. J Am Coll Cardiol 1994;24:828–33.
2. Achtelik M, Weismüller P, Trappe HJ, für die CPI Ventak AV II DR-Studie: Erste Erfahrungen mit einem implantierbaren Kardioverter/Defibrillator mit integrierter frequenzadaptiver Zweikammerschrittmacherfunktion in einer europäischen Multicenterstudie. Z Kardiol 1998;87Suppl 1:182. abstract.
3. Aliot E, Sadoul N, Chillou C: Role of atrioventricular node in atrial fibrillation: what have we learned from radiofrequency catheter modification of the atrioventricular junction in patients with refractory atrial fibrillation? J Cardiovasc Electrophysiol 1998;9:Suppl: S132–8.
4. Allessie MA, Wijffels MCEF, Dorland R. Mechanisms of pharmacologic cardioversion of atrial fibrillation by class I drugs. J Cardiovasc Electrophysiol 1998;9:Suppl:S69–77.
5. Alt E, Herrmann R. Intra-atrial defibrillation for atrial fibrillation: animal data. J Cardiovasc Electrophysiol 1998; 9:Suppl:163–9.